- Home
- CRGX vs ENX Comparison
CRGX vs ENX Comparison
Compare CRGX & ENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGX
- ENX
- Stock Information
- Founded
- CRGX 2021
- ENX 2002
- Country
- CRGX United States
- ENX United States
- Employees
- CRGX N/A
- ENX N/A
- Industry
- CRGX
- ENX Finance/Investors Services
- Sector
- CRGX
- ENX Finance
- Exchange
- CRGX Nasdaq
- ENX Nasdaq
- Market Cap
- CRGX 180.4M
- ENX 174.2M
- IPO Year
- CRGX 2023
- ENX N/A
- Fundamental
- Price
- CRGX $4.64
- ENX $9.24
- Analyst Decision
- CRGX Hold
- ENX
- Analyst Count
- CRGX 7
- ENX 0
- Target Price
- CRGX $4.67
- ENX N/A
- AVG Volume (30 Days)
- CRGX 653.7K
- ENX 25.4K
- Earning Date
- CRGX 05-13-2025
- ENX 01-01-0001
- Dividend Yield
- CRGX N/A
- ENX 3.94%
- EPS Growth
- CRGX N/A
- ENX N/A
- EPS
- CRGX N/A
- ENX 0.16
- Revenue
- CRGX N/A
- ENX N/A
- Revenue This Year
- CRGX $58.18
- ENX N/A
- Revenue Next Year
- CRGX N/A
- ENX N/A
- P/E Ratio
- CRGX N/A
- ENX $61.00
- Revenue Growth
- CRGX N/A
- ENX N/A
- 52 Week Low
- CRGX $3.00
- ENX $7.84
- 52 Week High
- CRGX $25.45
- ENX $10.07
- Technical
- Relative Strength Index (RSI)
- CRGX 59.08
- ENX 42.85
- Support Level
- CRGX $3.58
- ENX $8.74
- Resistance Level
- CRGX $4.17
- ENX $9.72
- Average True Range (ATR)
- CRGX 0.26
- ENX 0.21
- MACD
- CRGX 0.12
- ENX -0.02
- Stochastic Oscillator
- CRGX 92.98
- ENX 51.02
About CRGX CARGO Therapeutics Inc.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.
About ENX Eaton Vance New York Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance New York Municipal Bond Fund is principally engaged in managing investment funds and providing investment management and advisory services to high-net-worth individuals and institutions. It is a non-diversified, closed-end investment company. Its objective is to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in specified state.